Cargando…
Strategies for the Nonclinical Safety Assessment of Vaccines
Over the past century, vaccines have made a large impact on public health. Prophylactic vaccines prevent disability and disease, saving millions of dollars in potential health-care spending. Since prophylactic vaccines are administered to healthy individuals, including infants and children, it is im...
Autores principales: | Wolf, Jayanthi J., Plitnick, Lisa M., Herzyk, Danuta J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120100/ http://dx.doi.org/10.1007/978-1-4614-5380-2_16 |
Ejemplares similares
-
Book Review: Toxicologic Pathology, Nonclinical Safety Assessment
por: Yoshizawa, Katsuhiko
Publicado: (2014) -
Regulatory Consideration for the Nonclinical Safety Assessment of Gene Therapies
por: Moffit, Jeffrey S., et al.
Publicado: (2022) -
Practical approaches for evaluating adrenal toxicity in nonclinical safety assessment
por: Inomata, Akira, et al.
Publicado: (2015) -
Nonclinical Development of BCG Replacement Vaccine Candidates
por: Velmurugan, Kamalakannan, et al.
Publicado: (2013) -
Considerations for the Nonclinical Safety Evaluation of Antibody–Drug Conjugates
por: Fisher, J. Edward
Publicado: (2021)